United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85534-0003_559e72cb-a7f3-e1ed-e063-6294a90ad90a
- Product NDC
- 85534-0003
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- HAWAII REPACK, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160218
- Source listing expiry
- 20271231
Source-listed ingredients
- GABAPENTIN — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE, PLASTIC (85534-0003-0) · 85534-0003-0
- 60 CAPSULE in 1 BOTTLE, PLASTIC (85534-0003-1) · 85534-0003-1
- 90 CAPSULE in 1 BOTTLE, PLASTIC (85534-0003-2) · 85534-0003-2
- 120 CAPSULE in 1 BOTTLE, PLASTIC (85534-0003-3) · 85534-0003-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →